Table 2.

Direct Costs of Outpatient Infliximab Infusions in Pediatric IBD

IBD Type	Distribution of Costs
Crohn’s disease (n=53)
Pharmacy-related
Infliximab drug cost	22.6%
Other pharmacy costs	23.0%
Personnel (i.e., nursing, short stay unit staff)	31.8%
Other overhead (e.g., facilities, maintenance)	22.6%
Non-Drug Cost Per Infusion in CD	77.4%
Ulcerative colitis (n=23)
Pharmacy-related
Infliximab cost	22.7%
Other pharmacy costs	23.1%
Personnel (i.e., nursing, short stay unit staff)	31.5%
Other overhead (e.g., facilities, maintenance)	22.7%
Non-Drug Cost Per Infusion in UC	77.3%